Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection

Genes and Immunity

Volumn 16, Issue 5, 2015, Pages 297-300

  Ampuero, J ^a   Del Campo, J A ^a   Rojas, L ^a   Garcia Lozano R J ^b   Buti, M ^c   Sola R ^d   Forns, X ^e   Moreno Otero, R ^f   Andrade, R ^g   Diago, M ^h   Salmeron J ⁱ   Rodrigo, L ^j   Pons, J A ^k   Navarro, J M ^l   Calleja, J L ^m   Garcia Samaniego J ⁿ   Garcia Valdecasas M ^a   Rojas, A ^a   Millan R ^a   Gonzalez Escribano M F ^b   Romero Gomez M ^a   more..

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^h HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^j HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^l HOSPITAL COSTA DEL SOL   (Spain)

^m HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

ⁿ HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BTN2A1 PROTEIN; BTN3A2 PROTEIN; BTN3A3 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; BUTYROPHILIN; MEMBRANE PROTEIN;

ADULT; ARTICLE; CHRONIC HEPATITIS C; CONTROLLED STUDY; FEMALE; GENE MAPPING; GENETIC ANALYSIS; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIGENE FAMILY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL CLEARANCE; GENETICS; HEPACIVIRUS; HEPATITIS C; HOST PATHOGEN INTERACTION; VIROLOGY;

HEPATITIS C VIRUS;

GENOTYPE; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; MEMBRANE GLYCOPROTEINS; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; SELECTION, GENETIC;

EID: 84937818478     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2015.14     Document Type: Article

References (19)

1. Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J. InC3 Study Group. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology 2014; 59: 109-120.
2. Saito T, Ueno Y. Transmission of hepatitis C virus: self-limiting hepatitis or chronic hepatitis? World J Gastroenterol 2013; 19: 6957-6961.
3. Romero V, Azocar J, Zúñiga J, Clavijo OP, Terreros D, Gu X et al. Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Mol Immunol 2008; 45: 2429-2436.
4. Montes-Cano MA, Caro-Oleas JL, Romero-Gómez M, Diago M, Andrade R, Carmona I et al. HLA-C and KIR genes in hepatitis C virus infection. Hum Immunol 2005; 66: 1106-1109.
5. Cubero M, Gregori J, Esteban JI, Garciá-Cehic D, Bes M, Perales C et al. Identification of host and viral factors involved in a dissimilar resolution of a hepatitis C virus infection. Liver Int 2014; 34: 896-906.
6. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461: 798-801.
7. Zhu YZ, Qian XJ, Zhao P, Qi ZT. How hepatitis C virus invades hepatocytes: the mystery of viral entry. World J Gastroenterol 2014; 20: 3457-3467.
8. Rojas L, Ampuero J, Del Campo JA, Garcia-Lozano RJ, Solá R, Forns X et al. Fine mapping of the butyrophilin genomics region: Role in hepatitis C virus infection (HCV). J Hepatol 2014; 60: S139.
9. Bekker V, Chanock SJ, Yeager M, Hutchinson AA, von Hahn T, Chen S et al. Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection. J Viral Hepat 2010; 17: 192-200.
10. Viken MK, Blomhoff A, Olsson M, Akselsen HE, Pociot F, Nerup J et al. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex. Genes Immun 2009; 10: 323-333.
11. Le Page C, Marineau A, Bonza PK, Rahimi K, Cyr L, Labouba I et al. BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis. PLoS One 2012; 7: e38541.
12. Bamne M, Wood J, Chowdari K, Watson AM, Celik C, Mansour H et al. Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure. Schizophr Bull 2012; 38: 1149-1154.
13. Montes-Cano MA, Garciá-Lozano JR, Abad-Molina C, Romero-Gómez M, Barroso N, Aguilar-Reina J et al. Interleukin-28B genetic variants and hepatitis virus infection by different viral genotypes. Hepatology 2010; 52: 33-37.
14. Ampuero J, Romero-Gómez M, Reddy KR. Review article: HCV genotype 3-the new treatment challenge. Aliment Pharmacol Ther. 2014; 39: 686-698.
15. Horner SM, Gale M Jr. Regulation of hepatic innate immunity by hepatitis C virus. Nat Med 2013; 19: 879-888.
16. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004; 305: 872-874.
17. Terilli RR, Cox AL. Immunity and hepatitis C: a review. Curr HIV/AIDS Rep 2013; 10: 51-58.
18. Amadei B, Urbani S, Cazaly A, Fisicaro P, Zerbini A, Ahmed P et al. Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology 2010; 138: 1536-1545.
19. Messal N, Mamessier E, Sylvain A, Celis-Gutierrez J, Thibult ML, Chetaille B et al. Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. Eur J Immunol 2011; 41: 3443-3454.